Nexalin Technology Inc. (NXL) Stock Analysis

Nexalin Technology Inc. (NXL) is a publicly traded company in the HEALTHCARE sector. It trades at $0.45, carries a market capitalization of $9.74M. This page summarizes the public market data, fundamentals, and frequently asked questions for NXL, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - MEDICAL DEVICES

Exchange: NASDAQ

Key Metrics

Price: $0.45
Market Cap: $9.74M
EPS: $-0.50
52-Week High: $2.00
52-Week Low: $0.30

Market Sentiment

Nexalin Technology Inc. currently has a Neutral sentiment score of 0.07.

About Nexalin Technology Inc.

None

GNG Research Analysis

GNG Research scores Nexalin Technology Inc. (NXL) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for NXL.

Frequently Asked Questions

Does NXL pay dividends?

Nexalin Technology Inc. (NXL) does not currently pay a regular dividend.

What is NXL's market cap?

Nexalin Technology Inc. (NXL) has a market capitalization of $9.74M with a current stock price of $0.45.